Abstract:More than 170 different types of chemical modifications have been identified on diverse types of RNA, collectively known as the epitranscriptome. Among them, N6-methyladenine (m6A), 5-methylcytosine (m5C), N1-methyladenine (m1A), and N7-methylguanosine (m7G) as the ubiquitous post-transcriptional modification are widely involved in regulating the metabolic processes such as RNA degradation, translation, stability, and export, mediating important physiological and pathological processes such as stress regulation, immune response, development, and tumorigenesis. Recently, the regulatory role of RNA modification during developmental processes is getting more attention. Therefore, the development of low-input even single-cell and high-resolution sequencing technologies is crucial for the exploration of the regulatory roles of RNA modifications in these important biological events of trace samples.This account focuses on the roles of RNA modifications in various developmental processes. We describe the distribution characteristics of various RNA modifications, catalytic enzymes, binding proteins, and the development of sequencing technologies. RNA modification is dynamically reversible, which can be catalyzed by methyltransferases and eliminated by demethylases. RNA m6A is the most abundant post-transcriptional modification on eukaryote mRNA, which is mainly concentrated near the stop codon, and involves in RNA metabolism regulation. RNA m5C, another most studied RNA modification, has been identified in a various of organisms and RNA species, mainly enriched in the regions downstream of translation initiation sites and broadly distributes across the whole coding sequence (CDS) in mammalian mRNAs. RNA m1A, with a lower abundance than m6A, is widely distributed in various RNA types, mainly locates in the 5' untranslated region (5'UTR) of mRNA and regulates translation. RNA m7G, one of the most common RNA modifications in eukaryotes, has been identified at cap regions and internal positions of RNAs and recently gained considerable attention.Thanks to the development of sequencing technology, m6A has been found to regulate the tumorigenic process, including tumor proliferation, invasion, and metastasis by modulating oncogenes and tumor suppressor genes, and affect oocyte maturation and embryonic development through regulating maternal and zygotic genes. m5C related proteins have been identified to participate in embryonic development, plant growth, and neural stem cell differentiation in a m5C dependent manner. m1A also has been revealed to be involved in these developmental processes. m7G dysregulation mainly involves in neurodevelopmental disorders and neurodegenerative diseases.Collectively, we summarized the gradually exhibited roles of RNA methylation during development, and discussed the possibility of RNA modifications as candidate biomarkers and potential therapeutic targets. The technological development is anticipated as the major driving force to expand our knowledge in this field.

Methylation modifications in tRNA and associated disorders: Current research and potential therapeutic targets

Dysregulation of tRNA methylation in cancer: Mechanisms and targeting therapeutic strategies

tRNA modifications and tRNA-derived small RNAs: new insights of tRNA in human disease

RNA modification: mechanisms and therapeutic targets

RNA methylation in neurodevelopment and related diseases

Principles of RNA methylation and their implications for biology and medicine

tRNA Modifications and Dysregulation: Implications for Brain Diseases

tsRNA modifications: An emerging layer of biological regulation in disease

The functions and mechanisms of post-translational modification in protein regulators of RNA methylation: Current status and future perspectives

The Emerging Molecular Mechanism of M6a Modulators in Tumorigenesis and Cancer Progression

Advances in RNA Cytosine-5 Methylation: Detection, Regulatory Mechanisms, Biological Functions and Links to Cancer

RNA 5-Methylcytosine Modification: Regulatory Molecules, Biological Functions, and Human Diseases

RNA methylation: A potential therapeutic target in autoimmune disease

Post‐Translational Modifications of RNA‐Modifying Proteins in Cellular Dynamics and Disease Progression

Dysregulation of RNA modification systems in clinical populations with neurocognitive disorders

Emerging Roles of RNA Methylation in Development

RNA modifications: importance in immune cell biology and related diseases

RNA methylation‐related inhibitors: Biological basis and therapeutic potential for cancer therapy

The role of m6A modification in the biological functions and diseases

RNA methylations in depression, from pathological mechanism to therapeutic potential

When N7-methyladenosine modification meets cancer: Emerging frontiers and promising therapeutic opportunities